Coronary microembolization

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 1, 2004, Pages 23-31

  Heusch, Gerd ^a   Schulz, Rainer ^a   Haude, Michael ^a   Erbel, Raimund ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Acute coronary syndrome; Arrhythmia; Contractile dysfunction; Inflammation; Microinfarct; Plaque rupture

Indexed keywords

CYTOKINE;

ACUTE DISEASE; AUTOPSY; CONFERENCE PAPER; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DISEASE ACTIVITY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; EXPERIMENTATION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MEDICAL INSTRUMENTATION; MICROEMBOLISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SUDDEN DEATH; THROMBOCYTE; UNSTABLE ANGINA PECTORIS;

ANIMALS; ARTERIOSCLEROSIS; BLOOD PLATELETS; CORONARY ARTERIOSCLEROSIS; CYTOKINES; DEATH, SUDDEN; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; HEART DISEASES; HUMANS; INFLAMMATION; MICROCIRCULATION; MODELS, BIOLOGICAL; MYOCARDIUM; TIME FACTORS;

ANIMALIA;

EID: 3142545147     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.04.011     Document Type: Conference Paper

References (105)

1. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 50:1983;127-134
2. Davies M.J., Thomas A.C. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart J. 53:1985;363-373
3. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 71:1985;699-708
4. Davies M.J., Thomas A.C., Knapman P.A., Hangartner J.R. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation. 73:1986;418-427
5. Frink R.J., Rooney P.A., Trowbridge J.O., Rose J.P. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br Heart J. 59:1988;196-200
6. Erbel R., Heusch G. Brief review: coronary microembolization. J Am Coll Cardiol. 36:2000;22-24
7. Topol E.J., Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 101:2000;570-580
8. El-Maraghi N., Genton E. The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation. 62:1980;936-944
9. Bing R.J., Castellanos A., Gradel E., Lupton C., Siegel A. Experimental myocardial infarction: circulatory biochemical and pathologic changes. Am J Med Sci. 232:1956;533-554
10. West J.W., Kobayashi T., Anderson F.S. Effects of selective coronary embolization on coronary blood flow and coronary sinus venous blood oxygen saturation in dogs. Circ Res. 10:1962;722-738
11. Herzberg R.M., Rubio R., Berne R.M. Coronary occlusion and embolization: effect on blood flow in adjacent arteries. Am J Physiol. 210:1966;169-175
12. Hori M., Inoue M., Kitakaze M., Koretsune Y., Iwai K., Tamai J., et al. Role of adenosine in hyperemic response of coronary blood flow in microcirculation. Am J Physiol Heart Circ Physiol. 250:1986;H509-H518
13. Hori M., Tamai J., Kitakaze M., Iwakura K., Gotoh K., Iwai K., et al. Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol Heart Circ Physiol. 257:1989;H244-H251
14. Hori M., Gotoh K., Kitakaze M., Iwai K., Iwakura K., Sato H., et al. Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation. 84:1991;828-840
15. Takashima S., Hori M., Kitakaze M., Sato H., Inoue M., Kamada T. Superoxide dismutase restores contractile and metabolic dysfunction through augmentation of adenosine release in coronary microembolization. Circulation. 87:1993;982-995
16. Grund F., Sommerschild H.T., Lyberg T., Kirkeboen K., Ilebekk A. Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance. Am J Physiol Heart Circ Physiol. 277:1999;H533-H542
17. Skyschally A., Schulz R., Erbel R., Heusch G. Reduced coronary and inotropic reserves with coronary microembolization. Am J Physiol Heart Circ Physiol. 282:2002;H611-H614
18. Eng C., Cho S., Factor S.M., Sonnenblick E.H., Kirk E.S. Myocardial micronecrosis produced by microsphere embolization. Role of an alpha-adrenergic tonic influence on the coronary microcirculation. Circ Res. 54:1984;74-82
19. Heusch G. α-adrenergic mechanisms in myocardial ischemia. Circulation. 81:1990;1-13
20. Heusch G. Emerging importance of alpha-adrenergic coronary vasoconstriction in acute coronary syndromes and its genetic background. J Am Coll Cardiol. 41:2003;195-196
21. Möhlenkamp S., Beighley P.E., Pfeifer E.A., Behrenbeck T.R., Sheedy P.F. II, Ritman E.L. Intramyocardial blood volume, perfusion and transit time in response to embolization of different sized microvessels. Cardiovasc Res. 57:2003;843-852
22. Folts J.D., Crowell E.B., Rowe G.G. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 54:1976;365-370
23. Willerson J.T., Golino P., Eidt J., Campbell W.B., Buja L.M. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation. 80:1989;198-205
24. Folts J.D. Deleterious hemodynamic effects of thrombotic/embolic materials on the distal myocardial vasculature. Cardiovasc Res. 42:1999;6-7
25. Barrabés J.A., Garcia-Dorado D., Soriano B., Solares J., Puigfel Y., Trobo L., et al. Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization. Cardiovasc Res. 47:2000;265-273
26. Golino P., Buja M., Sheng-Kun Y., McNatt J., Willerson J.T. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo. J Am Coll Cardiol. 15:1990;718-726
27. Folts J.D., Gallagher K., Rowe G.G. Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation. 65:1985;248-255
28. Gallagher K.P., Osakada G., Kemper W.S., Ross J. Jr. Cyclical coronary flow reductions in conscious dogs equipped with ameroid constrictors to produce severe coronary narrowing. Basic Res Cardiol. 80:1985;100-106
29. Eidt J.F., Allison P., Ashton J., Golino P., McNatt J., Buja L.M., et al. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest. 84:1989;18-27
30. Bertha B.G., Folts J.D. Subendocardial and subepicardial segmental function changes in the dog heart due to gradual coronary flow reduction by an acutely developing thrombus. Cardiovasc Res. 19:1985;495-506
31. Kowey P.R., Verrier R.L., Lown B., Handin R.I. Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosis. Am J Cardiol. 51:1983;596-602
32. Mansaray M., Belcher P.R., Vergroesen I., Wright Z.M., Hynd J.W., Drake-Holland A.J., et al. Downstream resistance effects of intracoronary thrombosis in the stenosed canine coronary artery. Cardiovasc Res. 42:1999;193-200
33. Jorgensen L., Rowsell H.C., Hovig T., Glynn M.F., Mustard J.F. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest. 17:1967;616-644
34. Haft J.I., Kranz P.D., Albert F.J., Fani K. Intravascular platelet aggregation in the heart induced by norepinephrine. Circulation. 46:1972;698-708
35. Haft J.I., Gershengorn K., Kranz P.D., Oestreicher R. Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation. Am J Cardiol. 30:1972;838-843
36. Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res. 61:2004;498-511
37. Ross J. Jr. Myocardial perfusion-contraction matching. Circulation. 83:1991;1076-1083
38. Dörge H., Neumann T., Behrends M., Skyschally A., Schulz R., Kasper C., et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol. 279:2000;H2587-H2592
39. Dörge H., Schulz R., Belosjorow S., Post H., van de Sand A., Konietzka I., et al. Coronary microembolization: the role of TNFα in contractile dysfunction. J Mol Cell Cardiol. 34:2002;51-62
40. Skyschally A., Haude M., Dörge H., Thielmann M., Duschin A., van de Sand A., et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation. 109:2004;2337-2342
41. Arras M., Strasser R., Mohri M., Doll R., Eckert P., Schaper W., et al. Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol. 93:1998;97-107
42. Yokoyama T., Vaca L., Durante W., Hazarika P., Mann D.L. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest. 92:1993;2303-2312
43. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol Regul Integ Comp Physiol. 274:1998;R577-R595
44. Thielmann M., Dörge H., Martin C., Belosjorow S., Schwanke U., van de Sand A., et al. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-α and sphingosine. Circ Res. 90:2002;807-813
45. Hannun Y.A., Bell R.M. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 243:1989;500-507
46. Coroneos E., Martinez M., McKenna S., Kester M. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. J Biol Chem. 270:1995;23305-23309
47. Zamorano J., Erbel R., Ge J., Görge G., Kearney P., Koch L., et al. Spontaneous plaque rupture visualized by intravascular ultrasound. Eur Heart J. 15:1994;131-133
48. Ge J., Liu F., Kearney P., Görge G., Haude M., Baumgart D., et al. Intravascular ultrasound approach to the diagnosis of coronary artery aneurysm. Am Heart J. 130:1995;765-771
49. Ge J., Chirillo F., Schwedtmann J., Görge G., Haude M., Baumgart D., et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart. 81:1999;621-627
50. Gössl M., von Birgelen C., Mintz G.S., Böse D., Eggebrecht H., Baumgart D., et al. Volumetric assessment of ulcerated ruptured coronary plaques with three-dimensional intravascular ultrasound in vivo. Am J Cardiol. 91:2003;992-996
51. Ueda Y., Asakura M., Hirayama A., Komamura K., Hori M., Kodama K. Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction: serial angioscopic observations. J Am Coll Cardiol. 27:1996;606-610
52. van Belle E., Lablanche J.-M., Bauters C., Renaud N., McFadden E.P., Bertrand M.E. Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction. Natural history and the effect of thrombolysis. Circulation. 97:1998;26-33
53. Okamatsu K., Takano M., Sakai S., Ishibashi F., Uemura R., Takano T., et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation. 109:2004;465-470
54. Baumgart D., Liu F., Haude M., Görge G., Ge J., Erbel R. Acute plaque rupture and myocardial stunning in patient with normal coronary arteriography. Lancet. 346:1995;193-194
55. Kotani J., Mintz G.S., Pregowski J., Kalinczuk L., Pichard A.D., Satler L.F., et al. Volumetric intravascular ultrasound evidence that distal embolization during acute infarct intervention contributes to inadequate myocardial perfusion grade. Am J Cardiol. 92:2003;728-732
56. Prati F., Pawlowski T., Gil R., Labellarte A., Gziut A., Caradonna E., et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? Circulation. 107:2003;2320-2325
57. Hamm C.W., Ravkilde J., Gerhardt W., Jorgensen P., Peheim E., Ljungdahl L., et al. The prognostic value of serum troponin T in unstable angina. New Engl J Med. 327:1992;146-150
58. Brener S.J., Topol E.J. Troponin, embolization and restoration of microvascular integrity. Eur Heart J. 21:2000;1117-1119
59. Herrmann J., Volbracht L., Haude M., Eggebrecht H., Malyar N., Mann K., et al. Biochemische Marker bei ischämischen und nicht ischämischen Myokardschädigungen. Med Klin. 96:2001;144-156
60. Alpert J.S., Thygesen K. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J. 21:2000;1502-1513
61. PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. New Engl J Med. 338:1998;1488-1497
62. Hamm C.W., Heeschen C., Goldmann B., Vahanian A., Adgey J., Macaya Miguel C., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. New Engl J Med. 340:1999;1623-1629
63. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 94:1996;1528-1536
64. Califf R.M., Abdelmeguid A.E., Kuntz R.E., Popma J.J., Davidson C.J., Cohen E.A., et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 31:1998;241-251
65. Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Satler L.F., et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions. Circulation. 101:2000;604-610
66. Herrmann J., Haude M., Lerman A., Schulz R., Volbracht L., Ge J., et al. Abnormal coronary flow velocity reserve following coronary intervention is associated with cardiac marker elevation. Circulation. 103:2001;2339-2345
67. Williams M.J.A., Dow C.J., Newell J.B., Palacios I.F., Picard M.H. Prevalence and timing of regional myocardial dysfunction after rotational coronary atherectomy. J Am Coll Cardiol. 28:1996;861-869
68. Bowers T.R., Stewart R.E., O'Neill W.W., Reddy V.M., Safian R.D. Effect of rotablator atherectomy and adjunctive balloon angioplasty on coronary blood flow. Circulation. 95:1997;1157-1164
69. Ricciardi M.J., Wu E., Davidson C.J., Choi K.M., Klocke F.J., Bonow R.O., et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 103:2001;2780-2783
70. Mak K.-H., Challapalli R., Eisenberg M.J., Anderson K.M., Califf R.M., Topol E.J. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol. 80:1997;985-988
71. Neumann F.-J., Blasini R., Schmitt C., Alt E., Dirschinger J., Gawaz M., et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after placement of coronary-artery stents in acute myocardial infarction. Circulation. 98:1998;2701
72. Schömig A., Kastrati A., Dirschinger J., Mehilli J., Schricke U., Pache J., et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. New Engl J Med. 343:2000;385-391
73. Bonz A., Lengfelder B., Strotmann J., Held S., Turschner O., Harre K., et al. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol. 40:2002;622-628
74. Ritchie M.E. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation. 98:1998;1707-1713
75. Burke A.P., Tracy R., Virmani R. C-reactive protein as a risk factor for artherothrombosis: a post-mortem study. Lab Invest. 81:2001;43A. (abstract)
76. Cusack M.R., Marber M.S., Lambiase P.D., Bucknall C.A., Redwood S.R. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol. 39:2002;1917-1923
77. Heusch G., Schulz R., Erbel R. Inflammatory markers in coronary heart disease: coronary vascular versus myocardial origin? Circulation. 108:2003;e4
78. Herrmann J., Lerman A., Baumgart D., Volbracht L., Schulz R., von Birgelen C., et al. Pre-procedural statin medication reduces the extent of peri-procedural non-Q-wave myocardial infarction. Circulation. 106:2002;2180-2183
79. Werner N., Nickenig G., Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol. 97:2002;105-116
80. Eichhorn E., Grayburn P.A., Willard J.E., Anderson V., Bedotto J.B., Carry M., et al. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol. 17:1991;43-52
81. Anderson H.V., Kirkeeide R.L., Krishnaswami A., Weigelt L.A., Revana M., Weisman H.F., et al. Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal platelet antibody. J Am Coll Cardiol. 23:1994;1031-1037
82. Flynn M.S., Kern M.J., Aguirre F.V., Bach R.G., Caracciolo E.A., Donohue T.J. Alterations in coronary blood flow velocity during intracoronary thrombolysis and rescue coronary angioplasty for acute myocardial infarction. Catheter Cardiovasc Diag. 31:1994;219-224
83. Sunamura M., Di Mario C., Piek J.J., Schroeder E., Vrints C., Probst P., et al. Cyclic flow variations after angioplasty: a rare phenomenon predictive of immediate complications. Am Heart J. 131:1996;843-848
84. Nanto S., Kodama K., Hori M., Mishima M., Hirayama A., Inoue M., et al. Temporal increase in resting coronary blood flow causes an impairment of coronary flow reserve after coronary angioplasty. Am Heart J. 123:1992;28-36
85. Van Liebergen R.A.M., Piek J.J., Koch K.T., de Winter R.J., Lie K.I. Immediate and long-term effect of balloon angioplasty or stent implantation on the absolute and relative coronary blood flow velocity reserve. Circulation. 98:1998;2133-2140
86. Kern M.J., Puri S., Bach R.G., Donohue T.J., Dupouy P., Caracciolo E.A., et al. Abnormal coronary flow velocity reserve after coronary artery stenting in patients. Role of relative coronary reserve to assess potential mechanisms. Circulation. 100:1999;2491-2498
87. Gregorini L., Marco J., Farah B., Bernies M., Palombo C., Kozakova M., et al. Effects of selective α- and α2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation. 106:2002;2901-2907
88. Carlino M., De Gregorio J., Di Mario C., Anzuini A., Airoldi F., Albiero R., et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Circulation. 99:1999;3221-3223
89. Grube E., Gerckens U., Yeung A.C., Rowold S., Kirchhof N., Sedgewick J., et al. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation. 104:2001;2436-2441
90. Grube E., Schofer J., Webb J., Schuler G., Colombo A., Sievert H., et al. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol. 89:2002;941-945
91. Limbruno U., Micheli A., De Carlo M., Amoroso G., Rossini R., Palagi C., et al. Mechanical prevention of distal embolization during primary angioplasty. Safety, feasibility, and impact on myocardial reperfusion. Circulation. 108:2003;171-176
92. Sangiorgi G., Colombo A. Embolic protection devices. Heart. 89:2003;990-992
93. Baim D.S., Wahr D., George B., Leon M.B., Greenberg J., Cutlip D.E., et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 105:2002;1285-1290
94. Stone G.W., Rogers C., Hermiller J., Feldman R., Hall P., Haber R., et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 108:2003;548-553
95. Thuesen L., Falk E. Pathology of coronary microembolisation and no reflow. Heart. 89:2003;983-985
96. Kloner R.A., Ganote C.E., Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 54:1974;1496-1508
97. Ambrosio G., Weisman H.F., Mannisi J.A., Becker L.C. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 80:1989;1846-1861
98. Marzilli M., Orsini E., Marraccini P., Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 101:2000;2154-2159
99. Eeckhout E., Kern M.J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J. 22:2001;729-739
100. Heusch G., Schulz R. Hibernating myocardium. New answers, still more questions! Circ Res. 91:2002;863-865
101. Baker C.S.B., Dutka D.P., Pagano D., Rimoldi O., Pitt M., Hall R.J.C., et al. Immunocytochemical evidence for inducible nitric oxide synthase and cylooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Res Cardiol. 97:2002;409-415
102. Kalra D.K., Zhu X., Ramchandani M.K., Lawrie G., Reardon M.J., Lee-Jackson D., et al. Increased myocardial gene expression of tumor necrosis factor-α and nitric oxide synthase-2. A potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation. 105:2002;1537-1540
103. Sabbah H.N., Stein P.D., Kono T., Gheorghiade M., Levine T.B., Jafri S., et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol Heart Circ Physiol. 29:1991;H1379-H1384
104. Gössl M., Malyar N.M., Rosol M., Beighley P.E., Ritman E.L. Impact of coronary vasa vasorum functional structure on coronary vessel wall perfusion distribution. Am J Physiol Heart Circ Physiol. 285:2003;H2019-H2026
105. Skyschally A., Erbel R., Heusch G. Coronary microembolization. Circ J. 67:2003;279-286